K-numberK251093
Device nameBonvadis®
ApplicantOneness Biotech Co., Ltd.
Product codeFRO
Device classClass U
Decision dateJun 9, 2025
DecisionSubstantially Equivalent
Regulation
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Bonvadis® is a non-sterile, water-based, semi-viscous topical wound dressing supplied in a 15g aluminum tube for prescription use. It contains humectant and emollient ingredients including Centella Asiatica and Mexican Mint extracts, designed to maintain a moist wound environment conducive to healing. It is indicated for management of partial and full thickness wounds, post-surgical wounds, burns (1st and superficial 2nd degree), diabetic foot ulcers, venous stasis ulcers, and pressure ulcers.

Technological characteristics

Bonvadis® is substantially identical to predicate devices in being a non-sterile, water-based, preserved, semi-viscous formulation with neutral pH, topical delivery, and a mechanism of action providing moist wound environment. Key characteristics include: non-sterile status, humectant and emollient components for moisture donation, methyl and propyl paraben preservatives, and identical indications for use compared to predicate K232655.

Test standards cited

Testing was performed per USP standards including USP<61> (microbial limits), USP<62> (microbial limits), and USP<51> (preservative effectiveness). Non-clinical tests included shelf-life stability, in-use stability, transepidermal water loss (TEWL), water retention capacity, biocompatibility, toxicological risk assessment, usability, and transportation testing.

Substantial equivalence argument

Bonvadis® demonstrates substantial equivalence through identical intended use, indications, delivery system, mechanism of action, and sterility claim as the primary predicate K232655. Comprehensive non-clinical testing (stability, biocompatibility, preservative efficacy per USP standards, TEWL, water retention) confirmed the device performs comparably to predicates. The formulation's humectant and emollient components mirror predicate technology, and all quality parameters meet established criteria, establishing functional and performance equivalence without requiring clinical data.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →